![]() |
市場調查報告書
商品編碼
1722440
2025-2033年醫用導管市場報告(依產品、結構、應用、最終用戶和地區)Medical Tubing Market Report by Product, Structure, Application, End User, and Region 2025-2033 |
2024年全球醫用導管市場規模達145億美元。展望未來, IMARC Group預計到2033年市場規模將達到248億美元,2025-2033年期間的成長率(CAGR)為5.87%。癌症、關節炎和心血管疾病的發生率不斷上升,以及導管插入術中醫用導管的廣泛使用,推動了市場的成長。
主要市場促進因素:技術進步、老年人口增加、慢性病發病率激增以及家庭醫療保健市場的擴張正在刺激行業成長。此外,更高的醫療保健支出支持採用先進的醫療技術,從而進一步支持醫療管道市場的需求。
主要市場趨勢:醫療管設備小型化的傾向日益增強、客製化和個人化的需求、對病患舒適度和安全性的關注等是一些主要市場趨勢。此外,人們對使用生物相容性和生物可吸收材料製造醫療管的興趣日益濃厚。這些材料最大限度地降低了不良反應和組織損傷的風險,並且可以隨著時間的推移在體內安全分解,無需進行移除手術,從而進一步促進行業成長。
地理格局:根據報告,北美佔據最大的市場佔有率。北美是醫療技術創新的中心,重點是開發涉及醫療管的先進醫療設備。此外,管道材料、製造技術和設計的不斷進步也促進了市場的成長,提高了醫療管道的性能、安全性和功效。
競爭格局:一些領先的醫療導管市場公司包括 ATAG spa、Avient Corporation、Bentec Medical、Hitachi Ltd.、Microlumen Inc.、NewAge Industries Inc.、Nordson Corporation、Optinova、Spectrum Plastics Group、TE Connectivity Ltd.、Trelleborg AB 和 Vanguard Products Corporation 等。
挑戰與機會:嚴格的監管要求、成本壓力、對產品品質和安全日益成長的關注以及感染風險是市場面臨的一些主要挑戰。然而,個人化醫療趨勢的日益成長為根據個別患者需求量身定做的醫療管解決方案開闢了眾多醫療管市場機會。 3D 列印等技術能夠根據患者特定的解剖差異和臨床要求生產客製化醫療管,進一步增加市場需求。
微創手術需求不斷成長
對醫學侵入性手術的需求不斷增加確實對醫用導管市場的成長做出了重大貢獻。例如,根據 2022 年 1 月的文章《未來微創手術的微電子導管》,導管在微創手術中發揮重要作用,因為它們可以輕鬆去除血栓、植入植入物或精確地在需要的地方給藥。它們的設計也對患者特別溫和。此外,醫用導管在醫療保健環境中的各種應用中發揮著至關重要的作用,包括外科手術、診斷過程、藥物傳輸系統和靜脈治療等。隨著醫療技術的不斷進步,專業化、先進醫療導管的需求也不斷增加。例如,2023 年 9 月,全球先進聚合物解決方案提供商 Zeus 創造了 AbsorvTM XSE 定向管,這是其生物可吸收產品系列的最新成員。 Absorv XSE 是一個高度可調節的設計平台,為永久植入人體的金屬物品提供了替代品。它適用於多種樹脂並具有更大的尺寸範圍。此外,全球人口老化和慢性病的盛行率上升也增加了對侵入性手術的需求。心血管疾病、癌症和神經系統疾病等疾病通常需要依靠醫療管道進行精確治療。例如,根據 MD 安德森癌症中心 2024 年 4 月發表的文章,如果癌症患者因頭部或頸部癌症而吞嚥困難,或在癌症治療(包括手術、化療和放射治療)之前或期間營養不良,則可能需要餵食管。這些因素進一步促進了醫療導管市場佔有率的成長。
老年人口不斷增加
由於預期壽命延長,老齡人口正在顯著增加。例如,根據世界衛生組織的數據,60歲及以上人口的數量正在增加。 2019年,60歲以上人口已達10億人。到2030年,這一數字將上升到14億,到2050年將上升到21億。隨著老齡人口的成長,對各種醫療服務和設備的需求也在增加,包括那些使用醫用導管的服務和設備。醫用導管用途廣泛,例如靜脈 (IV) 管、導管、呼吸管和餵食管,老年人通常需要這些導管來治療各種健康狀況。根據美國國家醫學圖書館發表的一篇文章,鼻胃管餵食通常用於老年患者(65歲以上)因吞嚥困難和營養不良而進行。老年人的吞嚥困難通常由多種因素造成。此外,老年人口往往需要持續的醫療照護和支持,從而導致醫療導管產品的消費量增加。此外,醫療技術的進步促進了用於不同醫療程序的專用管道的開發,從而進一步增加了醫療管道市場的收入。例如,2022 年 12 月,科德寶醫療在 CPhl 和 PMEC 印度展會上推出了新產品 HelixFlex。本產品是一種高純度熱塑性彈性體 TPE 管,專門用於生物製藥流體輸送應用。
慢性病發生率激增
心血管、糖尿病、癌症等慢性疾病的發生率正在大幅上升,進一步推動了對醫用導管的需求。根據衛生指標與評估研究所2023年6月發布的報告,在每個國家,各個年齡層的男性、女性和兒童都受到糖尿病的影響,全球有超過5億人患有糖尿病。未來30年,預計這一數字將增加一倍以上,達到13億人,而且每個國家的人口都會增加。醫用導管在輸送藥物、液體和營養以及監測和管理這些狀況方面發揮著至關重要的作用。此外,許多慢性病需要持續用藥來控制症狀、控制病情進展或預防併發症。這些因素正在影響醫用導管市場的近期價格。醫用導管,例如靜脈 (IV) 管和輸液器,有助於安全有效地輸送藥物,包括化療藥物、胰島素、抗生素和止痛藥。例如,根據帕金森基金會 2022 年的資料更新,預計美國每年將有 9 萬人被診斷出患有帕金森氏症,到 2030 年,預計約有 120 萬美國人將患有這種疾病。與此一致,當某人患有這種疾病時,控制症狀會變得困難,因為腦細胞不會吸收左旋多巴和儲存多巴胺。在此期間服藥變得至關重要,輸液療法可以更持續地輸送藥物,並提供更一致、更可靠的症狀緩解。這些因素進一步對醫療導管市場預測產生了正面影響。
The global medical tubing market size reached USD 14.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.87% during 2025-2033. The rising prevalence of cancer, arthritis, and cardiovascular conditions, along with the widespread usage of medical tubing in catheterization, is propelling the market growth.
Major Market Drivers: Technological advancements, rising geriatric population, surging incidence of chronic diseases, and expanding home healthcare market are stimulating the industry growth. Additionally, higher healthcare expenditures support the adoption of advanced medical technologies, thereby further supporting the medical tubing market demand.
Key Market Trends: The growing inclination towards miniaturization of medical tube devices, demand for customization and personalization, focus on patient comfort and safety, etc., are some of the key market trends. Moreover, there's increasing interest in the use of biocompatible and bioresorbable materials for medical tubes. These materials minimize the risk of adverse reactions and tissue damage, and they can degrade safely within the body over time, eliminating the need for removal procedures, thereby further escalating the industry growth.
Geographical Landscape: According to the report, North America accounted for the largest market share. North America is a hub for medical technology innovation, with a strong focus on developing advanced medical devices, involving medical tubes. In addition, continuous advancements in tube materials, manufacturing techniques, and design contribute to the growth of the market by improving the performance, safety, and efficacy of medical tubes.
Competitive Landscape: Some of the leading medical tubing market companies are ATAG spa, Avient Corporation, Bentec Medical, Hitachi Ltd., Microlumen Inc., NewAge Industries Inc., Nordson Corporation, Optinova, Spectrum Plastics Group, TE Connectivity Ltd., Trelleborg AB, and Vanguard Products Corporation, among many others.
Challenges and Opportunities: Strict regulatory requirements, cost pressures, rising concern for product quality and safety, and infection risk are some of the key challenges that the market is facing. However, the rising inclination towards personalized medicine opens up numerous medical tubing market opportunities for customized medical tube solutions tailored to individual patient needs. Technologies like 3D printing enable the production of bespoke medical tubes based on patient-specific anatomical variations and clinical requirements, thereby further escalating the market demand.
Rising Demand for Minimally Invasive Procedures
The increasing demand for medically invasive procedures indeed contributes significantly to the growth of the medical tubing market. For instance, according to the January 2022 article ""Microelectronic Catheter for Minimally Invasive Surgery of the Future,"" catheters play a major role in minimally invasive surgery because they make it easy to remove blood clots, insert implants, or administer drugs precisely where they are needed. They are also designed to be especially gentle on patients. Moreover, medical tubing plays a crucial role in various applications within healthcare settings, including surgical procedures, diagnostic processes, drug delivery systems, and intravenous therapies, among others. As advancements in medical technology continue to evolve, the need for specialized and advanced medical tubing also rises. For instance, in September 2023, Zeus, an advanced polymer solutions provider around the world, created AbsorvTM XSE oriented tubing, the newest addition to its line of bioabsorbable products. Absorv XSE is a highly adjustable platform for design that offers an alternative to metallic items implanted permanently in the human body. It is available in a variety of resins and increased size ranges. Moreover, the aging population and the increasing prevalence of chronic diseases worldwide contribute to the demand for invasive procedures. Conditions, such as cardiovascular diseases, cancer, and neurological disorders often require interventions that rely on medical tubing for precise delivery of treatments. For instance, according to the article published by MD Anderson Cancer Center in April 2024, cancer patients might need a feeding tube if they have trouble swallowing due to cancer in the head or neck area or are malnourished before or during cancer treatment, including surgery, chemotherapy, and radiation therapy. These factors are further contributing to the medical tubing market share.
Increasing Geriatric Population
The aging population is increasing significantly owing to longer life expectancy. For instance, according to the World Health Organization, the number of people aged 60 and up in the population is increasing. In 2019, there were one billion people aged 60 and over. This figure will rise to 1.4 billion by 2030, and 2.1 billion by 2050. As the elderly population grows, there's an increased demand for various medical services and devices, including those that utilize medical tubing. Medical tubing is used in a wide range of applications, such as intravenous (IV) lines, catheters, respiratory tubing, and feeding tubes, which are commonly required by older individuals for managing various health conditions. According to an article published by the National Library of Medicine, nasogastric feeding is often used in elderly patients (over the age of 65) due to dysphagia and malnutrition. Dysphagia in older adults is usually multifactorial. Moreover, the aging population often requires ongoing medical care and support, leading to higher consumption of medical tubing products. Additionally, advancements in medical technology have led to the development of specialized tubing for different medical procedures, thereby further bolstering the medical tubing market revenue. For instance, in December 2022, Freudenberg Medical launched a new product, HelixFlex, at the CPhl and PMEC India. The product is a high-purity thermoplastic elastomer TPE tubing intended for use in biopharmaceutical fluid transfer applications.
Surging Incidences of Chronic Diseases
The incidence of chronic diseases such as cardiovascular, diabetes, cancer, etc., is experiencing a significant surge, thereby further driving the demand for medical tubing. According to a report published by the Institute for Health Metrics and Evaluation in June 2023, in every country, men, women, and children of all ages are affected by diabetes, which affects more than half a billion people globally. In the next 30 years, that figure is expected to more than double to 1.3 billion people, with an increase in every country. Medical tubing plays a crucial role in the delivery of medications, fluids, and nutrition, as well as in monitoring and managing these conditions. Moreover, many chronic conditions require ongoing medication to manage symptoms, control disease progression, or prevent complications. These factors are influencing the medical tubing market's recent prices. Medical tubing, such as intravenous (IV) lines and infusion sets, facilitates the safe and efficient delivery of medications, including chemotherapy drugs, insulin, antibiotics, and pain relievers. For instance, according to the Parkinson's Foundation's 2022 data update, 90,000 individuals in the U.S. are expected to receive a PD diagnosis each year, and by 2030, about 1.2 million Americans are expected to have the disease. In line with this, it gets difficult to control the symptoms when someone is suffering from this disease as brain cells don't absorb levodopa and store dopamine. It becomes crucial to take the drug during the time, infusion therapy delivers medication more continuously and provides more consistent and reliable symptom relief. These factors are further positively influencing the medical tubing market forecast.
Currently, polyvinyl chloride holds the majority of the total market share
According to the medical tubing market overview, polyvinyl chloride (PVC) medical tubing finds widespread usage across various medical applications due to its favorable properties, such as flexibility, durability, biocompatibility, and affordability. PVC tubing is extensively used in IV therapy for delivering fluids, medications, and blood products directly into the bloodstream. It is available in various lengths and diameters to accommodate different clinical needs. As healthcare spending continues to rise globally, there's a parallel demand for PVC medical tubing. Moreover, PVC tubing is often preferred for its cost-effectiveness compared to other materials like silicone or polyurethane, especially in applications where disposable tubing is used, further driving its adoption. For instance, in May 2021, Benvic, a PVC compound and ecological biopolymers specialist, announced that it would use its ModenPlast subsidiary in Northern Italy to look for material synergies and innovative products for the global medical markets.
Single-Lumen tubing consists of a single hollow channel and is commonly used in applications where a single fluid or gas needs to be transported, such as in IV lines, oxygen delivery systems, or simple drainage tubes. While co-extruded tubing involves the simultaneous extrusion of multiple layers of materials with different properties. Moreover, multi-lumen tubing contains multiple channels within the same tube. It is commonly used in medical devices where separate channels are needed for various functions, such as in catheters with separate lumens for medication delivery. Furthermore, tapered or bump tubing is designed with a gradual decrease or increase in diameter along its length, creating a tapered or bump feature. Also, braided tubing consists of multiple layers of materials with fibers braided around the inner tube. This construction provides increased strength, kink resistance, and burst pressure compared to non-braided tubing.
Bulk disposable tubing currently exhibits a clear dominance in the market
As per the medical tubing market overview, bulk disposable tubing offers cost advantages due to its mass production and single-use nature. Healthcare facilities can purchase these tubes in large quantities at competitive prices, reducing overall expenses. Moreover, disposable tubing minimizes the risk of cross-contamination and nosocomial infections compared to reusable tubing. After a single use, the tubing is discarded, eliminating the need for sterilization and reducing the chances of transmitting pathogens between patients. Furthermore, this tubing meets stringent regulatory requirements for medical devices, ensuring adherence to quality and safety standards. Manufacturers produce disposable tubing using materials that comply with regulatory standards for biocompatibility and sterility, providing reassurance to healthcare providers and patients. For instance, in November 2020, Olympus partnered with Ruhof Corporation to launch the Olympus Procedure Kits, and Hybrid Tubing, two new single-use and single-day devices that alleviate the possibility of cross-contamination.
Currently, hospitals and clinics account for the largest market share
Hospitals and clinics are primary settings for patient care and treatment, where medical tubing is extensively used in various medical procedures and therapies. From intravenous therapy and respiratory support to surgical interventions and diagnostic procedures, medical tubing plays a vital role in delivering fluids, medications, and gases to patients. Moreover, hospitals and clinics require medical tubing for a diverse range of applications across different departments and specialties. This includes intravenous administration sets, catheters, drainage tubes, endotracheal tubes, feeding tubes, and more. Each department within a hospital, such as emergency, intensive care, surgery, and obstetrics, relies on specific types of tubing tailored to their clinical needs. For instance, in November 2023, the Medical Research Council awarded the University of Nottingham £1.1 million to conduct human trials for the world's first endotracheal tube integrated with an optical fiber sensor.
North America currently dominates the global market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.
According to the medical tubing market statistics, North America boasts one of the highest healthcare expenditures globally. The continuous rise in healthcare spending, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology, contribute significantly to the growth of the medical tubing market. The region is a hub for medical innovations and technological advancements. Moreover, manufacturers are constantly developing new materials, designs, and manufacturing processes to enhance the performance, biocompatibility, and safety of medical tubing. These advancements attract investment and drive the market growth as healthcare providers seek cutting-edge solutions. For instance, in March 2022, Shockwave Medical, Inc., received FDA permission and introduced the Shockwave M5+ peripheral IVL catheter. The Shockwave M5+ catheter is specifically developed to reduce Intravascular Lithotripsy (IVL) treatment time, offer alternate access options, and expand IVL therapy to patients with bigger vessel diameters.
The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: